IDEXX Laboratories, Inc. (NASDAQ: IDXX), a global leader in veterinary diagnostics, veterinary practice software and water microbiology testing,…
Blog
Intranasal COVID-19 vaccine demonstrates single-dose efficacy in preclinical studies, in parallel with achievement of Phase 1 clinical milestone
Codagenix Inc., a clinical-stage synthetic biology company pioneering a novel platform for vaccines and oncolytic virus…
VBI Vaccines Reports New CPT Code Issued for a 3-Antigen Prophylactic Hepatitis B Vaccine
CAMBRIDGE, Mass.–(BUSINESS WIRE)–VBI Vaccines Inc. (Nasdaq: VBIV) (VBI), a biopharmaceutical company driven by immunology in the…
Varex Announces LUMEN 4336W Radiography Detector With IP68 Rating
SALT LAKE CITY–(BUSINESS WIRE)–Varex Imaging Corporation (Nasdaq: VREX) today announced the addition of the LUMEN 4336W…
Forte Biosciences, Inc. Reports Inducement Grants Under Nasdaq Listing Rules
TORRANCE, Calif.–(BUSINESS WIRE)–Forte Biosciences, Inc. (www.fortebiorx.com) (NASDAQ: FBRX), a clinical-stage biopharmaceutical company, today announced the issuance…
AMN Healthcare to Sponsor Float in Ticker-Tape Parade Honoring COVID-19 Essential Workers
DALLAS–(BUSINESS WIRE)–AMN Healthcare, the leader and innovator of healthcare talent solutions, will sponsor a float in…
Global Clinical Laboratory Services Market (2020 to 2026) – Featuring Quest Diagnostics, Sanofi & Sonic Healthcare Among Others
The global clinical laboratory services market is anticipated to grow at a CAGR of 6.4% during…
Naturally Informed to Host Active Nutrition: Mastering the Market June 29-30, 2021
WholeFoods Magazine and Trust Transparency Center today announced their sixth virtual event in their Naturally Informed…
Kessler Topaz Meltzer & Checker, LLP: Final Deadline Reminder for Peloton Interactive, Inc. Investors – PTON
The law firm of Kessler Topaz Meltzer & Check, LLP reminds investors of Peloton Interactive, Inc.…
Investigational 2 mg Dose of Ozempic® (semaglutide) Injection Demonstrates Superior Reductions in Blood Sugar vs Ozempic® 1 mg in Adults With Type 2 Diabetes in a Phase 3 Trial
Novo Nordisk today presented data showing that an investigational 2 mg dose of Ozempic® (semaglutide) injection provided…